Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
206.95
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
206.00 (100)
Ask (Size)
208.50 (100)
Prev. Close
206.95
Today's Range
206.95 - 206.95
52wk Range
140.68 - 215.19
Shares Outstanding
2,628,679,824
Dividend Yield
2.51%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Want Decades of Passive Income? 2 Stocks to Buy Right Now
↗
Today 8:43 EST
These income stocks could be great buys to add to your portfolio.
Via
The Motley Fool
Topics
Intellectual Property
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
As 2025 draws to a close, the pharmaceutical industry stands at a historic crossroads. The year was defined by a widening chasm between the "metabolic haves"—those profiting from the global obesity...
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
Performance
YTD
N/A
N/A
1 Month
+0.8%
+0.8%
3 Month
+11.2%
+11.2%
6 Month
+33.0%
+33.0%
1 Year
+43.1%
+43.1%
More News
Read More
S&P 500 Eyes 7,000 Milestone: Technical Breakout Sets the Stage for a High-Stakes 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Palantir Shares Retreat to $180.80 as Hawkish Fed Minutes and Institutional Rebalancing Cool Year-End Rally
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
ETFs
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
December 30, 2025
Via
MarketMinute
Topics
Product Recall
The S&P 500 Seesaw: Analyzing IVV’s Year-End Turbulence After a Record-Breaking 2025
December 30, 2025
Via
MarketMinute
Topics
ETFs
Economy
Retirement
Wall Street Stumbles at the Finish Line: S&P 500 and Nasdaq Fight to Break 3-Day Slide Amid Year-End Rebalancing
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
↗
December 30, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
Could These 3 "Recession-Proof" Dividend Stocks Surge 100% by 2031?
↗
December 29, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Intellectual Property
The Santa Claus Stumble: Markets Pivot from Record Highs to Year-End Consolidation
December 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
December 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Earnings
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
December 29, 2025
From
Johnson & Johnson
Via
Business Wire
Blue-Chip Bull Run: Dow Jones Eyes 50,000 Milestone Amidst 2026 Technical Pivot
December 26, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
December 26, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Johnson & Johnson Terminates Experimental Eczema Drug Study After It Fails To Show Benefit
↗
December 26, 2025
Via
Stocktwits
Johnson & Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss
↗
December 26, 2025
Via
Benzinga
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
December 26, 2025
Via
PredictStreet
Topics
Economy
Emissions
Product Recall
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
December 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
This Dividend ETF Could Quietly Make You a Multimillionaire Over Time
↗
December 24, 2025
Via
The Motley Fool
Topics
ETFs
Top 5 US Healthcare Stocks By Market Value
↗
December 24, 2025
Via
Stocktwits
Legal Seismic Shift: Johnson & Johnson Faces Record $1.5 Billion Talc Verdict as Bankruptcy Strategy Collapses
December 23, 2025
Via
MarketMinute
Topics
Bankruptcy
Bonds
Lawsuit
Frequently Asked Questions
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 206.95
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 12/31/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 544.01B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 544B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.